---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004002"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T08:30:53.600016+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio receives $2M grant from KRHP LLC; up to $10M non-dilutive funding

## Summary
- Initial $2M grant from KRHP LLC; additional $8M contingent on KRHP's review of activities.
- Funding is non-dilutive and will support development of off-the-shelf T cell therapies for cancers and viral infections.
- Tevogen may also use grant to expand AI efforts (Tevogen.AI) in partnership with Microsoft.
- KRHP LLC is affiliated with spouse of Dr. Manmohan Patel, an existing >5% beneficial owner of TVGN common stock.
- Grant is in addition to previously announced $36M loan agreement from Q2 2024.

## SEC filing metadata
- accession: 0001493152-25-004002
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315225004002/0001493152-25-004002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315225004002/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004002
- JSON: https://secwatch.observer/filing/0001493152-25-004002.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.